Shibo Jiang
Shibo Jiang
Verified email at
Cited by
Cited by
HIV-1 inhibition by a peptide
S Jiang, K Lin, N Strick, AR Neurath
Nature 365 (6442), 113-113, 1993
The spike protein of SARS-CoV—a target for vaccine and therapeutic development
L Du, Y He, Y Zhou, S Liu, BJ Zheng, S Jiang
Nature Reviews Microbiology 7 (3), 226-236, 2009
Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways
Y Ding, LI He, Q Zhang, Z Huang, X Che, J Hou, H Wang, H Shen, L Qiu, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
X Tian, C Li, A Huang, S Xia, S Lu, Z Shi, L Lu, S Jiang, Z Yang, Y Wu, ...
Emerging microbes & infections 9 (1), 382-385, 2020
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion …
S Liu, G Xiao, Y Chen, Y He, J Niu, CR Escalante, H Xiong, J Farmar, ...
The Lancet 363 (9413), 938-947, 2004
N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion
S Jiang, H Lu, S Liu, Q Zhao, Y He, AK Debnath
Antimicrobial agents and chemotherapy 48 (11), 4349-4359, 2004
Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide
J Münch, L Ständker, K Adermann, A Schulz, M Schindler, R Chinnadurai, ...
Cell 129 (2), 263-275, 2007
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
W Tai, L He, X Zhang, J Pu, D Voronin, S Jiang, Y Zhou, L Du
Cellular & molecular immunology 17 (6), 613-620, 2020
Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1
AK Debnath, L Radigan, S Jiang
Journal of medicinal chemistry 42 (17), 3203-3209, 1999
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
L Lu, Q Liu, Y Zhu, KH Chan, L Qin, Y Li, Q Wang, JFW Chan, L Du, F Yu, ...
Nature communications 5 (1), 1-12, 2014
Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120
S Liu, H Lu, J Niu, Y Xu, S Wu, S Jiang
Journal of Biological Chemistry 280 (12), 11259-11273, 2005
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
Y He, Y Zhou, S Liu, Z Kou, W Li, M Farzan, S Jiang
Biochemical and biophysical research communications 324 (2), 773-781, 2004
Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor
Y He, Y Xiao, H Song, Q Liang, D Ju, X Chen, H Lu, W Jing, S Jiang, ...
Journal of Biological Chemistry 283 (17), 11126-11134, 2008
Design of a Protein Surface Antagonist Based on α‐Helix Mimicry: Inhibition of gp41 Assembly and Viral Fusion
JT Ernst, O Kutzki, AK Debnath, S Jiang, H Lu, AD Hamilton
Angewandte Chemie International Edition 41 (2), 278-281, 2002
Tannin inhibits HIV-1 entry by targeting gp41
L Lu, SW Liu, SB Jiang, SG Wu
Acta Pharmacologica Sinica 25 (2), 213-218, 2004
A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein
S Jiang, K Lin, M Lu
Journal of virology 72 (12), 10213-10217, 1998
Identification of N-phenyl-N′-(2, 2, 6, 6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4
Q Zhao, L Ma, S Jiang, H Lu, S Liu, Y He, N Strick, N Neamati, ...
Virology 339 (2), 213-225, 2005
Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing …
Y He, H Lu, P Siddiqui, Y Zhou, S Jiang
The Journal of Immunology 174 (8), 4908-4915, 2005
Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41
S Liu, H Lu, Q Zhao, Y He, J Niu, AK Debnath, S Wu, S Jiang
Biochimica et Biophysica Acta (BBA)-General Subjects 1723 (1-3), 270-281, 2005
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Z Zhu, S Chakraborti, Y He, A Roberts, T Sheahan, X Xiao, LE Hensley, ...
Proceedings of the National Academy of Sciences 104 (29), 12123-12128, 2007
The system can't perform the operation now. Try again later.
Articles 1–20